Temasek Holdings’s Q32 Bio QTTB Stock Holding History

Temasek Holdings’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-313,943	Closed	-$1.08M	–	157
2024 Q4	$1.08M	Hold	313,943	–	–	﹤0.01%	128
2024 Q3	$14M	Hold	313,943	–	–	0.06%	86
2024 Q2	$5.64M	Hold	313,943	–	–	0.03%	83
2024 Q1	$5.35M	Sell	313,943 -1	-0%	-$14	0.03%	69
2023 Q4	$3.44M	Hold	313,944	–	–	0.02%	69
2023 Q3	$6.61M	Hold	313,944	–	–	0.04%	55
2023 Q2	$5M	Hold	313,944	–	–	0.03%	57
2023 Q1	$5.82M	Hold	313,944	–	–	0.03%	55
2022 Q4	$7.12M	Hold	313,944	–	–	0.04%	58
2022 Q3	$9.1M	Hold	313,944	–	–	0.05%	59
2022 Q2	$11.1M	Hold	313,944	–	–	0.06%	66
2022 Q1	$17.2M	Hold	313,944	–	–	0.07%	71
2021 Q4	$20.6M	Hold	313,944	–	–	0.07%	71
2021 Q3	$44.5M	Buy	313,944 +132,134	+73%	+$16.8M	0.16%	56
2021 Q2	$23.8M	Buy	181,810 +2,905	+2%	+$363K	0.08%	66
2021 Q1	$30.3M	Hold	178,905	–	–	0.12%	54
2020 Q4	$36.4M	Hold	178,905	–	–	0.16%	50
2020 Q3	$34.5M	Hold	178,905	–	–	0.17%	44
2020 Q2	$48.9M	Hold	178,905	–	–	0.29%	34
2020 Q1	$50M	Hold	178,905	–	–	0.37%	32
2019 Q4	$66.7M	Hold	178,905	–	–	0.44%	31
2019 Q3	$58.3M	Hold	178,905	–	–	0.43%	33
2019 Q2	$63M	Hold	178,905	–	–	0.45%	33
2019 Q1	$89.3M	Hold	178,905	–	–	0.62%	29
2018 Q4	$72M	Hold	178,905	–	–	0.5%	33
2018 Q3	$73.6M	Hold	178,905	–	–	0.43%	38
2018 Q2	$65.7M	Hold	178,905	–	–	0.35%	41
2018 Q1	$60.2M	Buy	+178,905	New	+$60.2M	0.33%	39

Other funds holding QTTB

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Temasek Holdings's QTTB Position: Q1 2025 in Review

Temasek Holdings sold out of Q32 Bio (QTTB) in Q1 2025, closing a stake of 313,943 shares — an estimated $1.08M sold.

Temasek Holdings first reported a position in QTTB in Q1 2018 and held it in 28 quarters. The position peaked at $89.3M in Q1 2019. 73 funds tracked by Wall St. Rank hold QTTB as of Q1 2025.

Temasek Holdings reported no remaining Q32 Bio position as of Q1 2025 after selling out during the quarter.
Temasek Holdings sold 313,943 Q32 Bio shares in Q1 2025, an estimated $1.08M.
Temasek Holdings first reported a position in Q32 Bio in Q1 2018 and held it in 28 quarters.
Temasek Holdings's Q32 Bio position peaked at $89.3M in Q1 2019.
73 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2025.

Based on Temasek Holdings's 13F filing for Q1 2025, filed 16 May 2025.